RU2002135626A - Новая форма (r)-n-[5метил-8-(4-метилпиперазин-1-ил)-1,2,3,4-тетрагидро-2-нафтил]-4-мор фолинобензамида - Google Patents

Новая форма (r)-n-[5метил-8-(4-метилпиперазин-1-ил)-1,2,3,4-тетрагидро-2-нафтил]-4-мор фолинобензамида

Info

Publication number
RU2002135626A
RU2002135626A RU2002135626/04A RU2002135626A RU2002135626A RU 2002135626 A RU2002135626 A RU 2002135626A RU 2002135626/04 A RU2002135626/04 A RU 2002135626/04A RU 2002135626 A RU2002135626 A RU 2002135626A RU 2002135626 A RU2002135626 A RU 2002135626A
Authority
RU
Russia
Prior art keywords
methylpiperazin
tetrahydro
morpholinobenzamide
monohydrobromide
naphthyl
Prior art date
Application number
RU2002135626/04A
Other languages
English (en)
Inventor
Пер-Олов БЕРГСТРЁМ (SE)
Пер-Олов БЕРГСТРЁМ
Мартин ХЕДБЕРГ (SE)
Мартин ХЕДБЕРГ
Мона ЛИНДСТРЁМ (SE)
Мона ЛИНДСТРЁМ
Эрика СТОХЛЕ (SE)
Эрика СТОХЛЕ
Original Assignee
Астразенека Аб (Se)
Астразенека Аб
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Астразенека Аб (Se), Астразенека Аб filed Critical Астразенека Аб (Se)
Publication of RU2002135626A publication Critical patent/RU2002135626A/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Claims (4)

1. Форма А моногидробромида (R)-N-[5-метил-8-(4-метилпиперазин-1-ил)-1,2,3,4-тетрагидро-2-нафтил]-4-морфолинобензамида.
2. Форма А моногидробромида (R)-N-[5-метил-8-(4-метилпиперазин-1-ил)-1,2,3,4-тетрагидро-2-нафтил]-4-морфолинобензамида по п.1, которая представляет собой по существу кристаллографически чистую Форму А моногидробромида (R)-N-[5-метил-8-(4-метилпиперазин-1-ил)-1,2,3,4-тетрагидро-2-нафтил]-4-морфолинобензамида.
3. Форма А моногидробромида (R)-N-[5-метил-8-(4-метилпиперазин-1-ил)-1,2,3,4-тетрагидро-2-нафтил]-4-морфолинобензамида по п.2, содержащая не более 10% любой другой кристаллической формы моногидробромида (R)-N-[5-метил-8-(4-метилпиперазин-1-ил)-1,2,3,4-тетрагидро-2-нафтил]-4-морфолинобензамида.
4. Форма А моногидробромида (R)-N-[5-метил-8-(4-метилпиперазин-1-ил)-1,2,3,4-тетрагидро-2-нафтил]-4-морфолинобензамида по п.1, дающая картину дифракции рентгеновских лучей на порошке, демонстрирующую по существу следующие d-значения и относительные интенсивности.
RU2002135626/04A 2000-07-20 2001-07-17 Новая форма (r)-n-[5метил-8-(4-метилпиперазин-1-ил)-1,2,3,4-тетрагидро-2-нафтил]-4-мор фолинобензамида RU2002135626A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0002729A SE0002729D0 (sv) 2000-07-20 2000-07-20 Novel compound form
SE0002729-2 2000-07-20

Publications (1)

Publication Number Publication Date
RU2002135626A true RU2002135626A (ru) 2004-07-27

Family

ID=20280557

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2002135626/04A RU2002135626A (ru) 2000-07-20 2001-07-17 Новая форма (r)-n-[5метил-8-(4-метилпиперазин-1-ил)-1,2,3,4-тетрагидро-2-нафтил]-4-мор фолинобензамида

Country Status (24)

Country Link
US (1) US6706710B2 (ru)
EP (1) EP1305303A1 (ru)
JP (1) JP2004504390A (ru)
KR (1) KR20030015398A (ru)
CN (1) CN1443178A (ru)
AR (1) AR029588A1 (ru)
AU (2) AU2001272872B2 (ru)
BR (1) BR0112619A (ru)
CA (1) CA2415046A1 (ru)
CZ (1) CZ2003140A3 (ru)
EE (1) EE200300028A (ru)
HU (1) HUP0301116A3 (ru)
IL (1) IL153836A0 (ru)
IS (1) IS6679A (ru)
MX (1) MXPA03000439A (ru)
NO (1) NO20030220L (ru)
NZ (1) NZ523528A (ru)
PL (1) PL365112A1 (ru)
RU (1) RU2002135626A (ru)
SE (1) SE0002729D0 (ru)
SK (1) SK732003A3 (ru)
UA (1) UA72333C2 (ru)
WO (1) WO2002008212A1 (ru)
ZA (1) ZA200300129B (ru)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ590616A (en) 2008-06-20 2012-09-28 Astrazeneca Ab Dibenzothiazepine derivatives and use thereof
GB201111704D0 (en) 2011-07-07 2011-08-24 Takeda Pharmaceutical Novel compounds
GB201111705D0 (en) 2011-07-07 2011-08-24 Takeda Pharmaceutical Compounds and their use
JO3115B1 (ar) 2011-08-22 2017-09-20 Takeda Pharmaceuticals Co مركبات بيريدازينون واستخدامها كمثبطات daao
GB201209587D0 (en) 2012-05-30 2012-07-11 Takeda Pharmaceutical Therapeutic compounds
US10208016B2 (en) 2013-06-21 2019-02-19 Takeda Pharmaceutical Company Limited 1-sulfonyl piperidine derivatives as modulators of prokineticin receptors
GB201314286D0 (en) 2013-08-08 2013-09-25 Takeda Pharmaceutical Therapeutic Compounds
GB201318222D0 (en) 2013-10-15 2013-11-27 Takeda Pharmaceutical Novel compounds
GB201320905D0 (en) 2013-11-27 2014-01-08 Takeda Pharmaceutical Therapeutic compounds
TW201613864A (en) 2014-02-20 2016-04-16 Takeda Pharmaceutical Novel compounds
GB201616839D0 (en) 2016-10-04 2016-11-16 Takeda Pharmaceutical Company Limited Therapeutic compounds
GB201619514D0 (en) 2016-11-18 2017-01-04 Takeda Pharmaceuticals Co Novel compounds
JP2021138648A (ja) 2020-03-04 2021-09-16 武田薬品工業株式会社 経口固形製剤

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9601110D0 (sv) * 1996-03-22 1996-03-22 Astra Ab Substituted 1,2,3,4-tetrahydronaphthalene derivatives
SE9900190D0 (sv) * 1999-01-22 1999-01-22 Astra Ab New compounds
SE9702799D0 (sv) 1997-07-25 1997-07-25 Astra Ab New compounds

Also Published As

Publication number Publication date
AU7287201A (en) 2002-02-05
SE0002729D0 (sv) 2000-07-20
WO2002008212A1 (en) 2002-01-31
NO20030220L (no) 2003-03-14
KR20030015398A (ko) 2003-02-20
PL365112A1 (en) 2004-12-27
AR029588A1 (es) 2003-07-02
NZ523528A (en) 2004-09-24
SK732003A3 (en) 2003-08-05
CN1443178A (zh) 2003-09-17
MXPA03000439A (es) 2003-06-24
JP2004504390A (ja) 2004-02-12
US20030166653A1 (en) 2003-09-04
CA2415046A1 (en) 2002-01-31
UA72333C2 (en) 2005-02-15
IS6679A (is) 2003-01-14
EE200300028A (et) 2004-10-15
IL153836A0 (en) 2003-07-31
NO20030220D0 (no) 2003-01-16
AU2001272872B2 (en) 2005-08-25
HUP0301116A2 (hu) 2003-08-28
CZ2003140A3 (cs) 2003-06-18
US6706710B2 (en) 2004-03-16
ZA200300129B (en) 2004-06-25
EP1305303A1 (en) 2003-05-02
HUP0301116A3 (en) 2006-03-28
BR0112619A (pt) 2003-07-29

Similar Documents

Publication Publication Date Title
RU2002135626A (ru) Новая форма (r)-n-[5метил-8-(4-метилпиперазин-1-ил)-1,2,3,4-тетрагидро-2-нафтил]-4-мор фолинобензамида
ES2133769T3 (es) Procedimiento para la sintesis diastereoselectiva de analogos de nucleosidos.
TW222625B (ru)
SE9802974D0 (sv) New crystalline forms
ATE79622T1 (de) 1,4-diazepine.
HRP20030853B1 (en) Crystalline form of omeprazole
JP2001354766A5 (ru)
DE69912992D1 (de) Zeolithisches material vom faujasite-typ
DE69111607D1 (de) Reine kristalline form von rifapentin.
RU2002124524A (ru) Производные n-деацетилтиоколхицина и содержащие их фармацевтические композиции
USD254762S (en) Combined toothbrush and dental floss holder
JP2004517145A5 (ru)
DE69940922D1 (de) Polymorphe Form B von 3-(Cyclopropylmethoxy)-4-i4-(methylsulfonyl)phenyl -5,5-dimethyl-5H-furan-2-on
ES2081608T3 (es) Zeolita kl que contiene hierro.
JPS57156467A (en) 2,4-disubstituted-6-quinazolinesulfonamide derivative
MA22435A1 (fr) Une variete nouvelle de rosier de la classe des hybrides de the, a grandes fleurs, generalement uniflore (variete: pekcourui)
MA22434A1 (fr) Une variete nouvelle de rosier de la classe des hybrides de the, a grandes fleurs, generalement uniflore (variete: pekcougraine)
MA22433A1 (fr) Une variete nouvelle de rosier de la classe des hybrides de the, a grandes fleurs, generalement uniflore (variete: pekcoulemon)
MA22427A1 (fr) Une variete nouvelle de rosier de la classe des hybrides de the, a grandes fleurs, generalement uniflore (variete: pekcenkatorz)
MA22422A1 (fr) Une variete nouvelle de rosier de la classe des hybrides de the, a grandes fleurs, generalement uniflore (variete: pekcouliste)
MA22421A1 (fr) Une variete nouvelle de rosier de la classe des hybrides de the, a grandes fleurs, generalement uniflore (variete: pekcoupink)
MA22419A1 (fr) Une variete nouvelle de rosier de la classe des hybrides de the, a grandes fleurs, generalement uniflore (variete: pekcoujachere)
JP2000100236A5 (ru)
MA22426A1 (fr) Une variete nouvelle de rosier de la classe des hybrides de the, a grandes fleurs, generalement uniflore (variete: pekcougelosia)
MA22431A1 (fr) Une variete nouvelle de rosier de la classe des hybrides de the, a grandes fleurs, generalement uniflore (variete: pekcoumage)

Legal Events

Date Code Title Description
FA92 Acknowledgement of application withdrawn (lack of supplementary materials submitted)

Effective date: 20050714